These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30402489)

  • 1. Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia.
    Barale C; Frascaroli C; Senkeev R; Cavalot F; Russo I
    Biomed Res Int; 2018; 2018():6508709. PubMed ID: 30402489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin.
    Ferroni P; Martini F; Cardarello CM; Gazzaniga PP; Davi G; Basili S
    Circulation; 2003 Oct; 108(14):1673-5. PubMed ID: 14504184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):463-7. PubMed ID: 15311154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
    Szczeklik A; Musiał J; Undas A; Gajewski P; Góra P; Swadźba J; Jankowski M
    J Am Coll Cardiol; 1999 Apr; 33(5):1286-93. PubMed ID: 10193729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up.
    Barale C; Bonomo K; Frascaroli C; Morotti A; Guerrasio A; Cavalot F; Russo I
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):282-291. PubMed ID: 31653513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects.
    Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Maesano A; Schepis F; Zema MC; Campo GM; Squadrito F; Saitta A
    Atherosclerosis; 2001 Mar; 155(1):143-7. PubMed ID: 11223435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases.
    Oka H; Ikeda S; Koga S; Miyahara Y; Kohno S
    Heart Vessels; 2008 Jul; 23(4):249-56. PubMed ID: 18649055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent effect of statins on platelet function in hypercholesterolaemia.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Angori P; Auteri A; Bruni F
    Eur J Clin Invest; 2002 Dec; 32(12):901-8. PubMed ID: 12534449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hyperactivity after statin treatment discontinuation.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Leo A; Cercignani M; Palazzuoli A; Auteri A; Bruni F
    Thromb Haemost; 2003 Sep; 90(3):476-82. PubMed ID: 12958617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of moderate and high dose simvastatin on adhesion molecules in severe hypercholesterolemia after targeting the LDL-cholesterol--a randomised, placebo-controlled study.
    Vladimirova-Kitova LG; Deneva TI; Nikolov FP
    Folia Med (Plovdiv); 2011; 53(2):13-21. PubMed ID: 21797102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments.
    Desideri G; Croce G; Tucci M; Passacquale G; Broccoletti S; Valeri L; Santucci A; Ferri C
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5341-7. PubMed ID: 14602771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identical LDL-cholesterol lowering but non-identical effects on NF-κB activity: High dose simvastatin vs combination therapy with ezetimibe.
    Rudofsky G; Reismann P; Groener JB; Djuric Z; Fleming T; Metzner C; Grafe IA; Bierhaus A; Nawroth PP
    Atherosclerosis; 2012 Jul; 223(1):190-6. PubMed ID: 22633472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia.
    Hernandez-Mijares A; Bañuls C; Rovira-Llopis S; Diaz-Morales N; Escribano-Lopez I; de Pablo C; Alvarez A; Veses S; Rocha M; Victor VM
    Atherosclerosis; 2016 Apr; 247():40-7. PubMed ID: 26868507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
    Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin.
    Barale C; Frascaroli C; Cavalot F; Russo I
    Thromb Res; 2019 Aug; 180():74-85. PubMed ID: 31229924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects.
    Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Sawamura T; Gioffre WR; Auteri A; Puccetti L
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):417-28. PubMed ID: 16244767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble P-selectin and proinflammatory cytokines in patients with polygenic type IIa hypercholesterolemia.
    Ferroni P; Basili S; Vieri M; Martini F; Labbadia G; Bellomo A; Gazzaniga PP; Cordova C; Alessandri C
    Haemostasis; 1999; 29(5):277-85. PubMed ID: 10754380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble P-selectin as a marker of in vivo platelet activation.
    Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
    Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.
    Hussein O; Minasian L; Itzkovich Y; Shestatski K; Solomon L; Zidan J
    Br J Clin Pharmacol; 2008 May; 65(5):637-45. PubMed ID: 18241285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.